Latest publications
The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies
A Delphi consensus statement. Mult Scler. 2021 Mar;27(3):331-346
Moiola L, Barcella V, Benatti S, Capobianco M, Capra R, Cinque P, Comi G, Fasolo MM, Franzetti F, Galli M, Gerevini S, Meroni L, Origoni M, Prosperini L, Puoti M, Scarpazza C, Tortorella C, Zaffaroni M, Riva A.
Vaccinations in patients with multiple sclerosis
A Delphi consensus statement. Mult Scler. 2021 Mar;27(3):347-359
Riva A, Barcella V, Benatti SV, Capobianco M, Capra R, Cinque P, Comi G, Fasolo MM, Franzetti F, Galli M, Gerevini S, Meroni L, Origoni M, Prosperini L, Puoti M, Scarpazza C, Tortorella C, Zaffaroni M, Moiola L.
Vaccination opportunities in multiple sclerosis patients treated with cladribine tablets
Curr Neuropharmacol 2021 Dec 17.
Moiola L, Riva A, Nicoletti F, Uccelli A, Salvetti M, Battistini L, Furlan R.
Covisep study groups. DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France
Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744.
Sormani MP, Salvetti M, Labauge P, Schiavetti I, Zephir H, Carmisciano L, Bensa C, De Rossi N, Pelletier J, Cordioli C, Vukusic S, Moiola L, Kerschen P, Radaelli M, Théaudin M, Immovilli P, Casez O, Capobianco M, Ciron J, Trojano M, Stankoff B, Créange A, Tedeschi G, Clavelou P, Comi G, Thouvenot E, Battaglia MA, Moreau T, Patti F, De Sèze J, Louapre C; Musc-19;
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study
Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2):e1141.
Iaffaldano P, Lucisano G, Manni A, Paolicelli D, Patti F Capobianco M, Brescia Morra V, Sola P, Pesci I, Lus G, De Luca G, Lugaresi A, Cavalla P, Montepietra S, Maniscalco GT, Granella F, Ragonese P, Vianello M, Brambilla L, Totaro R, Toscano S, Malucchi S, Petracca M, Moiola L, Ferraro D, Lepore V, Mosconi P, Ponzio M, Tedeschi G, Comi G, Battaglia MA, Filippi M, Amato MP, Trojano M; Italian MS Register.
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset
Neurology. 2022 Apr 19;98(16):e1626-e1636.
Portaccio E, Bellinvia A, Razzolini L, Pastò L, Goretti B, Niccolai C, Fonderico M, Zaffaroni M, Pippolo L, Moiola L, Falautano M, Celico C, Viterbo R, Patti F, Chisari C, Gallo P, Riccardi A, Borghi M, Bertolotto A, Simone M, Pozzilli C, Bianchi V, Roscio M, Martinelli V, Comi G, Filippi M, Trojano M, Ghezzi A, Amato MP; MS Study Group of the Italian Neurological Society.
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years
Mult Scler. 2022 Mar 16:13524585221079598.
Portaccio E, Pastò L, Razzolini L, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Gasperini C, Paolicelli D, Simone M, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Comi G, Filippi M, Trojano M, Amato MP.
Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression
Neurol Neuroimmunol Neuroinflamm. 2022 Feb 1;9(2):e1139
Preziosa P, Pagani E, Meani A, Moiola L, Rodegher M, Filippi M, Rocca MA.
Mult Scler
2022 Jun 20:13524585221102158
Guerrera G, Mandelli A, Finardi A, Orrico M, D'Orso S, Picozza M, Noviello M, Beretta V, Bonetti B, Calabrese M, Marastoni D, De Rossi N, Capra R, Salvetti M, Buscarinu MC, Inglese M, Uccelli A, Moiola L, Raposo C, Muros-Le Rouzic E, Pedotti R, Filippi M, Bonini C, Battistini L, Borsellino G, Furlan R.
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis
J Neurol Neurosurg Psychiatry 2022 Sep 30; jnnp-2022-329657
Landi D, Bovis F, Grimaldi A, Annovazzi PO, Bertolotto A, Bianchi A, Borriello G, Brescia Morra V, Bucello S, Buscarinu MC, Caleri F, Capobianco M, Capra R, Cellerino M, Centonze D, Cerqua R, Chisari CG, Clerico M, Cocco E, Cola G, Cordioli C, Curti E, d'Ambrosio A, D'Amico E, De Luca G, Di Filippo M, Di Lemme S, Fantozzi R, Ferraro D, Ferraro E, Gallo A, Gasperini C, Granella F, Inglese M, Lanzillo R, Lorefice L, Lus G, Malucchi S, Margoni M, Mataluni G, Mirabella M, Moiola L, Nicoletti CG, Nociti V, Patti F, Pinardi F, Portaccio E, Pozzilli C, Ragonese P, Rasia S, Salemi G, Signoriello E, Vitetta F, Totaro R, Sormani MP, Amato MP, Marfia GA.
Effects of Fingolimod and Natalizumab on Brain T1-/T2-Weighted and Magnetization Transfer Ratios: a 2-Year Study
Neurotherapeutics. 2021 Jan 22.
Preziosa P, Storelli L, Meani A, Moiola L, Rodegher M, Filippi M, Rocca MA.
In vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology
Brain. 2020 Nov 21:awaa379.
De Meo E, Storelli L, Moiola L, Ghezzi A, Veggiotti P, Filippi M, Rocca MA.
Application of deep-learning to the seronegative side of the NMO spectrum
J Neurol. 2022 Mar;269(3):1546-1556.
Cacciaguerra L, Storelli L, Radaelli M, Mesaros S, Moiola L, Drulovic J, Filippi M, Rocca MA.
Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis
Mult Scler. 2020 Sep 25:1352458520961690.
Ferrè L, Mogavero A, Clarelli F, Moiola L, Sangalli F, Colombo B, Martinelli V, Comi G, Filippi M, Esposito F.
Neural stem cell transplantation in patients with progressive multiple sclerosis: An open label, phase I study
Nature Medicine, in press 2022
Genchi A, Brambilla E, Sangalli F, Radaelli M, Bacigaluppi M, Furlan R, Andolfo A, Drago D, Magagnotti C, Scotti GM, Raffaella Greco R, Vezzulli P, Ottoboni L, Bonopane M, Capilupo D, Ruffini F, Daniela Belotti D, Cabiati B, Cesana S, Matera G, Leocani L, Martinelli V, Moiola L, Vago L, Panina-Bordignon P, Falini A, Ciceri F, Uglietti A,Sormani MP, Comi G, Battaglia MA, Rocca M, Storelli L, Pagani E, Gaipa G, Martino G.
